哪些上市公司年报业绩预计大幅亏损？ 黄金概念股大涨 今日（1月21日），A股市场维持窄幅震荡，上证指数收盘微涨0.08%。全天A股成交2.62万亿元，降至1月以来次低水平。黄金概念、玻璃基板、锂矿、先 进封装、CPO概念等涨幅居前。 黄金概念近日持续火爆，最新指数已创历史新高。盘面上，概念股招金黄金、白银有色（维权）、四川黄金、西部黄金、国城矿业（维权）等均录得涨停 板。 招金黄金（000506）目前已连续收获3个涨停板，拉长时间来看，该股近两年来涨幅惊人，以最新收盘价与近两年来的低点相比，招金黄金最大涨幅已达 到20.72倍，是同期黄金概念及有色金属行业涨幅最高的股票。 公开资料显示，招金黄金营业收入主要为黄金产品销售和房屋租赁收入，其中黄金销售业务占比达到98%以上。2025年前三季度，公司实现净利润0.82亿 元，同比扭亏为盈。 公司近日接受机构调研时表示，瓦图科拉金矿尾矿约1800万吨，品位约1g/t—1.5g/t，回收率约40%。目前瓦图科拉金矿排水工作已基本完成，正在进行采 场作业面恢复工作。 国晟科技（维权）遭遇5个跌停 1月21日早盘，国晟科技（603778）开盘跌停，收盘时跌停板封单达94. ...

Core Viewpoint - *ST Bio has experienced a decline in stock price and is facing significant challenges, including a warning of potential delisting due to negative net profit and insufficient revenue for 2024 [1][4]. Company Announcements - *ST Bio plans to acquire 51% of Hunan Huize Biomedical Technology Co., Ltd. in cash, which will constitute a major asset restructuring [2][4]. - The company and its subsidiaries will engage in lithium carbonate futures hedging, with a maximum margin balance of 3 million RMB and a maximum contract value of 30 million RMB on any trading day [1][2]. - Due to a negative net profit for 2024 and revenue below the required standard, *ST Bio's stock has been placed under delisting risk warning [2][4]. Governance and Compliance - The company has established a "Commodity Futures Trading Management System" to ensure trading is solely for hedging purposes, with regular audits and risk control assessments [2]. - A "Board and Senior Management Departure System" has been implemented, detailing the process for resignations and the obligations of departing personnel [3].

Core Viewpoint - The company, Nanhua Biological, is planning to engage in lithium carbonate futures hedging to mitigate raw material price volatility risks, with a maximum margin balance of 3 million yuan and a maximum contract value of 30 million yuan, using its own funds until September 30, 2026 [1][2][4]. Trading Information Summary - As of January 5, 2026, Nanhua Biological's stock closed at 8.82 yuan, down 1.45%, with a turnover rate of 0.76% and a trading volume of 25,000 hands, amounting to a transaction value of 22.0662 million yuan [1]. - On the same day, the net outflow of main funds was 6.0909 million yuan, while retail investors showed a net inflow of 3.8144 million yuan [1][3]. Company Announcement Summary - The 12th Board of Directors of Nanhua Biological held its 7th meeting on December 30, 2025, approving several resolutions, including the selection of an accounting firm, management of director and senior management departures, and the establishment of a commodity futures trading management system [1][2][3]. - The company has established a system for selecting accounting firms, detailing the conditions, procedures, and supervision requirements for hiring, renewing, or changing accounting firms, emphasizing quality management in the selection process [2]. - A departure management system for directors and senior management has been implemented, outlining procedures for resignation, work handover, and post-departure obligations [3][4]. - The commodity futures trading management system has been set up to regulate trading activities, ensuring that transactions are solely for hedging purposes and not speculative [4]. Feasibility Analysis of Hedging Business - Nanhua Biological aims to conduct lithium carbonate futures hedging to stabilize its main business operations against price fluctuations, with a maximum margin of 3 million yuan and a maximum contract value of 30 million yuan, funded by its own resources [1][4]. - The business is set to be implemented by the company and its subsidiaries, with the approval of the board of directors, and does not require shareholder meeting approval [4]. Regulatory Compliance and Risk Management - The company has established risk control measures and management systems to ensure that the hedging activities are conducted within the authorized limits set by the board of directors [1][4]. - West Securities, as the sponsor, has reviewed the hedging business and found no objections, confirming that it does not involve raised funds [4].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年12月31日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 香港小輪(集團)有限公司 | | | 呈交日期: | 2026年1月2日 | | | I. 法定/註冊股本變動 不適用 | | | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00050 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 356,273,883 | | 0 | | 356,273,883 | | 增加 / 減少 (-) | | | 0 | ...

Group 1 - The company *ST Bio (000504.SZ) announced that non-independent director Chen Wenbo submitted a written resignation due to personal reasons [1] - Chen Wenbo has resigned from his position as a non-independent director of the company's 12th board, as well as from the Strategic Committee and the Nomination Committee [1] - Following his resignation, Chen Wenbo will no longer hold any position within the company [1]

Group 1 - The company *ST Bio (000504.SZ) announced the receipt of a government subsidy related to revenue, amounting to 4.8 million yuan [1] - This subsidy represents 24.19% of the company's most recent audited net profit attributable to shareholders [1] - The subsidy is provided in cash and has been allocated to the company's relevant fund account as of December 11, 2025 [1]

| 截至月份: | 2025年11月30日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 香港小輪(集團)有限公司 | | | 呈交日期: | 2025年12月1日 | | | I. 法定/註冊股本變動 不適用 | | | FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 第 1 頁 共 10 頁 v 1.1.1 FF301 FF301 III.已發行股份及/或庫存股份變動詳情 (A). 股份期權（根據發行人的股份期權計劃） 不適用 第 3 頁 共 10 頁 v 1.1.1 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00050 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | ...

Core Viewpoint - *ST Bio (000504.SZ) aims to revitalize its existing assets and optimize its financial structure by transferring part of its accounts receivable to Hunan Caixin Asset Management Co., Ltd. [1] Group 1: Financial Transactions - The company held the 12th Independent Director's Fourth Special Meeting and the 12th Board of Directors' Fifth Meeting on November 14, 2025, to approve the proposal for debt transfer and related transactions [1] - The accounts receivable to be transferred have a book balance of 59.6689 million yuan as of December 31, 2024, with a cumulative provision for bad debts of 36.2545 million yuan, resulting in a book value of 23.4144 million yuan [1] - The preliminary agreement states that Caixin Asset will acquire the accounts receivable for no less than 23.4144 million yuan, with the final transaction price to be determined by a formal debt transfer agreement [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年10月31日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 香港小輪(集團)有限公司 | | | 呈交日期: | 2025年11月3日 | | | I. 法定/註冊股本變動 不適用 | | | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00050 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 356,273,883 | | 0 | | 356,273,883 | | 增加 / 減少 (-) | | | 0 | ...

Core Viewpoint - The news provides an overview of the upcoming IPOs, earnings announcements, shareholder meetings, and dividend distributions for various companies listed on the Hong Kong Stock Exchange as of October 23, 2025 [1]. New IPO Activities - Companies currently in the IPO process include: - Baima Tea Industry - Cambridge Technology - Sany Heavy Industry - Dipu Technology - Prada - Lijuz Pharmaceutical [1] Earnings Announcement Dates - Companies scheduled to announce earnings include: - Faraday - Ping An Good Doctor - Longyuan Power - Orient Overseas International - Qingdao Port - China Innovation Investment - Chongqing Machinery and Electric [1] Shareholder Meeting Dates - Companies holding shareholder meetings include: - Datang Power - Andeli Juice - Hongye Futures - Tibet Water Resources - China Anshun Energy [1] Dividend Distribution - Companies with upcoming dividend distributions include: - Hang Seng Bank (ex-dividend date) - Huaxun (dividend payment date) - Wansichang International (dividend payment date) - Zhifeng Industrial Electronics (dividend payment date) - Haitian Flavoring and Food (dividend payment date) - China Shipbuilding Defense (dividend payment date) - Dongfang Xingye Holdings (dividend payment date) - China Resources Mixc Life (dividend payment date) [1][3][4]